BiotechTube
Home/Papyrus Therapeutics/Prof Adam Marsh, PhD
PA

Prof Adam Marsh, PhD

AI/ML Bioinformatics

Papyrus Therapeutics

Therapeutic Areas

OncologyInflammatory Diseases

Papyrus Therapeutics Pipeline

DrugIndicationPhase
PYTX-004Ovarian Cancer (incl. Clear Cell)IND-Enabling
PYTX-004 + IOSolid Tumors (Combination)Preclinical

Leadership Team at Papyrus Therapeutics

PH
Prof Hani Gabra, PhD FRCP
Founder & President
PJ
Prof James Lorens, PhD
Board Director & SAB Chair
View full Papyrus Therapeutics profile